Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaspar Broch

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Heart (British Cardiac Society)|April 23, 2017
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarctionEspen Holte, Ola Kleveland, Thor Ueland, et al.
Scientific Reports|June 16, 2017
Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathyAurelija Abraityte, Ida G Lunde, Erik T Askevold, et al.
ESC Heart Failure|August 9, 2018
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trialCristiane C K Mayerhofer, Ayodeji O Awoyemi, Samuel D Moscavitch, et al.
European Heart Journal|May 11, 2016
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trialOla Kleveland, Gabor Kunszt, Marte Bratlie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 15, 2019
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejectionMarius Trøseid, Cristiane C K Mayerhofer, Kaspar Broch, et al.
Journal of Cardiovascular Translational Research|May 6, 2017
The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated CardiomyopathyHilde M Norum, Kaspar Broch, Annika E Michelsen, et al.
Matrix Biology Plus|December 11, 2023
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis developmentAthiramol Sasi, Andreas Romaine, Pugazendhi Murugan Erusappan, et al.
International Journal of Cardiology|October 7, 2024
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCISindre Woxholt, Thor Ueland, Pål Aukrust, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Heart Rhythm|June 18, 2022
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trialTove-Elizabeth Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Heart (British Cardiac Society)|April 23, 2017
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarctionEspen Holte, Ola Kleveland, Thor Ueland, et al.
Scientific Reports|June 16, 2017
Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathyAurelija Abraityte, Ida G Lunde, Erik T Askevold, et al.
ESC Heart Failure|August 9, 2018
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trialCristiane C K Mayerhofer, Ayodeji O Awoyemi, Samuel D Moscavitch, et al.
European Heart Journal|May 11, 2016
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trialOla Kleveland, Gabor Kunszt, Marte Bratlie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 15, 2019
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejectionMarius Trøseid, Cristiane C K Mayerhofer, Kaspar Broch, et al.
Journal of Cardiovascular Translational Research|May 6, 2017
The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated CardiomyopathyHilde M Norum, Kaspar Broch, Annika E Michelsen, et al.
Matrix Biology Plus|December 11, 2023
Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis developmentAthiramol Sasi, Andreas Romaine, Pugazendhi Murugan Erusappan, et al.
International Journal of Cardiology|October 7, 2024
Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCISindre Woxholt, Thor Ueland, Pål Aukrust, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Heart Rhythm|June 18, 2022
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trialTove-Elizabeth Hunt, Gunn Marit Traaen, Lars Aakerøy, et al.
Pageof 10